Taking home the top accolade of JTL National Apprentice of the Year was Stephanie Hitch, a plumbing apprentice from Redditch ...

Addepar, the data platform for wealth, investment, and asset management, announced the acquisition of Arcus, an enterprise AI workflow platform. Terms of the transaction were not disclosed. “Addepar ...

Arcus acquired a majority stake in FixMap in September Net is the second add-on under Arcus’ ownership FixMap is a Polish FTTH operator founded in 2018 Arcus Infrastructure Partners portfolio ...

Arcus Biosciences (NYSE:RCUS) will release its quarterly earnings report on Tuesday, 2025-05-06. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Arcus ...

If you want to know who really controls Arcus Biosciences, Inc. (NYSE:RCUS), then you'll have to look at the makeup of its share registry. With 51% stake, institutions possess the maximum shares ...

Gilead Sciences has defied analysts’ expectations by passing on its chance to license Arcus Biosciences’ potential rival to Merck & Co.’s kidney cancer drug Welireg. Gilead had the right to ...

The 8BitDo Retro Mechanical Keyboard is one of the most visually striking keyboards I’ve ever tested, sporting a retro design inspired by the likes of Nintendo. It’s built really well ...

With new data out on Arcus Biosciences’ experimental HIF-2a inhibitor, one group of analysts figures the company could give Merck’s Welireg a run for its money in kidney cancer. In the phase 1 ...

Arcus Infrastructure Partners has acquired a majority stake in FixMap, a Warsaw-based fiber-to-the-home business. This is the sixth acquisition for Arcus’ third fund, AEIF3, and Arcus’ third ...

During the last three months, 4 analysts shared their evaluations of Arcus Biosciences (NYSE:RCUS), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of their ...

Jan 29 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Monday it has raised its stake in Arcus Biosciences (RCUS.N), opens new tab to 33% and expanded its presence in the drug ...